Holen Sie sich die Stockscreener-App
1.45
0.00%
0.00
Schlusskurs vom Vortag:
$1.45
Offen:
$1.39
24-Stunden-Volumen:
6,458
Relative Volume:
0.37
Marktkapitalisierung:
$68.66M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.51M
KGV:
-7.6316
EPS:
-0.19
Netto-Cashflow:
$-10.96M
1W Leistung:
+14.17%
1M Leistung:
-5.84%
6M Leistung:
-19.67%
1J Leistung:
+1.40%
1-Tages-Spanne:
$1.39
$1.45
1-Wochen-Bereich:
$1.26
$1.45
52-Wochen-Spanne:
$1.12
$2.55
Medicinova Inc Stock (MNOV) Company Profile
Firmenname
Medicinova Inc
Sektor
Branche
Telefon
858-373-1500
Adresse
4275 EXECUTIVE SQUARE, LA JOLLA, CA
Vergleichen Sie MNOV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MNOV
Medicinova Inc
|
1.45 | 68.66M | 0 | -9.51M | -10.96M | -0.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Medicinova Inc Stock (MNOV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-03-10 | Eingeleitet | Maxim Group | Buy |
| 2019-03-25 | Fortgesetzt | B. Riley FBR | Buy |
| 2018-03-28 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2017-04-18 | Eingeleitet | Credit Suisse | Outperform |
| 2013-01-04 | Bestätigt | Ladenburg Thalmann | Buy |
| 2012-05-24 | Herabstufung | MLV & Co | Buy → Hold |
| 2011-10-18 | Bestätigt | MLV Capital | Buy |
| 2011-06-22 | Eingeleitet | Global Hunter Securities | Buy |
| 2010-05-12 | Eingeleitet | Wedbush | Outperform |
| 2008-11-12 | Bestätigt | Ladenburg Thalmann | Buy |
| 2008-05-15 | Eingeleitet | Rodman & Renshaw | Mkt Outperform |
| 2007-07-09 | Eingeleitet | Punk, Ziegel & Co | Buy |
Alle ansehen
Medicinova Inc Aktie (MNOV) Neueste Nachrichten
We Think MediciNova (NASDAQ:MNOV) Can Afford To Drive Business Growth - Yahoo Finance
MediciNova (NASDAQ:MNOV) Coverage Initiated at StockNews.com - Defense World
MediciNova To Participate in D. Boral's Capital Global Conference on May 14, 2025 - The Manila Times
MediciNova To Participate in D. Boral’s Capital Global Conference on May 14, 2025 - GlobeNewswire
MediciNova Secures Spotlight at Exclusive Healthcare Conference: CEO to Reveal Latest Pipeline Progress - Stock Titan
Meta CEO Mark Zuckerberg takes the stand in historic antitrust trial - The Globe and Mail
MediciNova’s (MNOV) “Buy” Rating Reiterated at D. Boral Capital - Defense World
Texas Instruments (TXN) Stock Trades Down, Here Is Why - The Globe and Mail
First Patient Enrolled in NIH-Funded Expanded Access - GlobeNewswire
This Stock Has More Than Doubled Already in 2025. Is It a Buy? - The Globe and Mail
MediciNova (NASDAQ:MNOV) Now Covered by Analysts at StockNews.com - Defense World
MEDICINOVA INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus
Why AppLovin (APP) Shares Are Trading Lower Today - The Globe and Mail
MediciNova (NASDAQ:MNOV) Now Covered by StockNews.com - The AM Reporter
MediciNova (NASDAQ:MNOV) Coverage Initiated by Analysts at StockNews.com - Defense World
Carter's (CRI): Buy, Sell, or Hold Post Q4 Earnings? - The Globe and Mail
3 Reasons to Avoid CSX and 1 Stock to Buy Instead - The Globe and Mail
StockNews.com Begins Coverage on MediciNova (NASDAQ:MNOV) - Defense World
Idiopathic Pulmonary Fibrosis Management Market Top Companies - openPR
Y Intercept Hong Kong Ltd Makes New $78,000 Investment in MediciNova, Inc. (NASDAQ:MNOV) - Defense World
Should You Forget Tesla and Buy 2 Artificial Intelligence (AI) Stocks Right Now? - The Globe and Mail
StockNews.com Initiates Coverage on MediciNova (NASDAQ:MNOV) - Defense World
Pulmonary Fibrosis Therapeutics Market Size in the 7MM - openPR
MKS Instruments to Participate in Cantor Fitzgerald Global Technology Conference - The Globe and Mail
Idiopathic Pulmonary Fibrosis Management Market Key Players - openPR
D. Boral Capital Reiterates Buy Rating for MediciNova (NASDAQ:MNOV) - The AM Reporter
MediciNova (NASDAQ:MNOV) Issues Earnings Results - MarketBeat
MediciNova (NASDAQ:MNOV) Releases Quarterly Earnings Results, Meets Estimates - MarketBeat
MediciNova (MNOV) to Release Quarterly Earnings on Thursday - MarketBeat
MediciNova (MNOV) Projected to Post Quarterly Earnings on Thursday - Defense World
Quantum Biopharma Engages Enterprise Canada and Empire Market Ventures to Lead Public Communications and Investor Awareness Programs - The Globe and Mail
US Exchange Penny Stocks To Watch In January 2025 - Yahoo Finance
MediciNova (NASDAQ:MNOV) Earns Hold Rating from Analysts at StockNews.com - Defense World
Jane Street Group LLC Takes $30,000 Position in MediciNova, Inc. (NASDAQ:MNOV) - Defense World
MediciNova (NASDAQ:MNOV) Share Price Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
MediciNova (NASDAQ:MNOV) Stock Crosses Above 200-Day Moving AverageWhat's Next? - MarketBeat
MediciNova, Inc. (NASDAQ:MNOV) Shares Acquired by Geode Capital Management LLC - Defense World
Why Amazon’s Next Earnings Could Trigger a Stock Breakout - The Globe and Mail
MediciNova (NASDAQ:MNOV) Shares Pass Above 200-Day Moving Average – Time to Sell? - Defense World
MediciNova (NASDAQ:MNOV) Stock Passes Above 200-Day Moving AverageHere's What Happened - MarketBeat
Finanzdaten der Medicinova Inc-Aktie (MNOV)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):